Integrated Investment Consultants LLC Sells 137 Shares of UnitedHealth Group Incorporated (NYSE:UNH)
Integrated Investment Consultants LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 9.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,253 shares of the healthcare conglomerate’s stock after selling 137 shares during the quarter. Integrated Investment Consultants LLC’s holdings in UnitedHealth Group were worth $391,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also recently added to or reduced their stakes in UNH. Vanguard Group Inc. lifted its holdings in UnitedHealth Group by 7.5% during the 2nd quarter. Vanguard Group Inc. now owns 80,727,140 shares of the healthcare conglomerate’s stock worth $23,810,470,000 after buying an additional 5,654,194 shares during the last quarter. Fisher Asset Management LLC lifted its holdings in UnitedHealth Group by 41,127.3% during the 2nd quarter. Fisher Asset Management LLC now owns 2,347,070 shares of the healthcare conglomerate’s stock worth $692,268,000 after buying an additional 2,341,377 shares during the last quarter. Nordea Investment Management AB increased its position in shares of UnitedHealth Group by 103.1% during the second quarter. Nordea Investment Management AB now owns 2,827,796 shares of the healthcare conglomerate’s stock worth $817,176,000 after purchasing an additional 1,435,755 shares in the last quarter. GQG Partners LLC increased its position in shares of UnitedHealth Group by 50.0% during the second quarter. GQG Partners LLC now owns 2,105,870 shares of the healthcare conglomerate’s stock worth $621,353,000 after purchasing an additional 702,164 shares in the last quarter. Finally, Two Sigma Advisers LP increased its position in shares of UnitedHealth Group by 195.8% during the second quarter. Two Sigma Advisers LP now owns 760,600 shares of the healthcare conglomerate’s stock worth $224,339,000 after purchasing an additional 503,500 shares in the last quarter. 86.39% of the stock is currently owned by institutional investors and hedge funds.
In other UnitedHealth Group news, Director Stephen J. Hemsley sold 98,579 shares of the firm’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $329.47, for a total value of $32,478,823.13. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Marianne D. Short sold 10,336 shares of the firm’s stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $312.34, for a total transaction of $3,228,346.24. Insiders sold 135,915 shares of company stock worth $44,372,099 in the last three months. 0.80% of the stock is currently owned by corporate insiders.
Shares of UNH stock traded down $11.31 during trading hours on Wednesday, hitting $309.20. 216,912 shares of the company were exchanged, compared to its average volume of 4,187,595. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.84 and a current ratio of 0.82. UnitedHealth Group Incorporated has a one year low of $187.72 and a one year high of $335.65. The business’s 50-day simple moving average is $314.32 and its two-hundred day simple moving average is $302.32. The stock has a market capitalization of $304.59 billion, a price-to-earnings ratio of 17.88, a P/E/G ratio of 1.53 and a beta of 0.68.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 EPS for the quarter, topping the consensus estimate of $2.98 by $0.53. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The business had revenue of $65.12 billion for the quarter, compared to analysts’ expectations of $63.97 billion. During the same quarter last year, the company posted $3.88 earnings per share. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 16.78 EPS for the current fiscal year.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Featured Article: What is the return on assets (ROA) ratio?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.